A phase II trial of paclitaxel (Taxol�) as first line treatment in advanced breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Link
http://link.springer.com/content/pdf/10.1007/BF00873803.pdf
Reference17 articles.
1. Wani MC, Taylor HL, Wall ME, Coggan P, McPhail AT: Plant antitumor agents VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from taxus brevifolia. Am Chem Soc 93:2325?2327, 1971
2. Manfredi JJ, Horwitz SB: Taxol: an antimitotic agent with a new mechanism of action. Pharmacol Ther 25:83?125, 1984
3. Schiff PB, Fant J, Horwitz SB: Promotion of microtubule assemblyin vitro by taxol. Nature 22:665?667, 1979
4. McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, Donehower RC: Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Int Med 111:273?279, 1989
5. Oken MM, Creech RH, Tormey DC, Horton J, Davis TC, McFadden ET, Carbone PPI: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649?655, 1982
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Morin reverses P‐glycoprotein‐mediated multidrug‐resistance in KBChR‐8‐5 cancer cell lines;Cell Biochemistry and Function;2024-06-28
2. Characterization and heterologous reconstitution of Taxus biosynthetic enzymes leading to baccatin III;Science;2024-02-09
3. Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies;Biomedicine & Pharmacotherapy;2023-04
4. Rutin and Hesperidin Alleviate Paclitaxel-Induced Nephrocardiotoxicity in Wistar Rats via Suppressing the Oxidative Stress and Enhancing the Antioxidant Defense Mechanisms;Evidence-Based Complementary and Alternative Medicine;2023-02-22
5. Hydrogen peroxide-triggered small molecule theranostics for cancer therapy: A review;2ND INTERNATIONAL CONFERENCE ON RECENT ADVANCES IN COMPUTATIONAL TECHNIQUES;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3